Category: Vaccine Development

Researchers at the Massachusetts Institute of Technology have introduced a groundbreaking AI-powered model named VaxSeer, designed to enhance the efficacy of the annual flu vaccine. By leveraging artificial intelligence, VaxSeer aims to predict the dominant flu strains for the upcoming year, anticipate their evolution, and assess the performance of vaccines against these strains. This innovation […]

In a decisive move, Governor Kathy Hochul of New York announced the extension of an executive order allowing pharmacists to prescribe and administer COVID-19 vaccines to any New Yorker requesting one. This proactive measure comes in response to the recent debates and changes in vaccine accessibility, highlighting the critical role of state leadership in ensuring […]

Ferritin, a well-known iron storage protein, has emerged as a versatile nanocarrier and a promising platform for vaccine development, particularly against challenging viruses like SARS-CoV-2. This review delves into the structural and functional properties of ferritin, highlighting its self-assembly mechanisms and unique features that make it an ideal candidate for vaccine delivery. The ability to […]

In the annals of India’s medical history lies a chapter that narrates the transformation of the country’s vaccine industry from a colonial testing ground to a global powerhouse. This journey, chronicled in the book ‘Vaccine Nation: How Immunization Shaped India’ by Ameer Shahul, delves into the pivotal events that shaped the trajectory of vaccine development […]

House appropriators have made a significant move by including funding for messenger RNA (mRNA) vaccine research in their 2026 spending bill, in direct contradiction to Health and Human Services Secretary Robert F. Kennedy Jr.’s efforts to halt such funding. Kennedy had previously announced the termination of grants supporting mRNA vaccine development, citing concerns about their […]

In the realm of vaccine development, the discussion surrounding the necessity and ethics of placebo testing has sparked a heated debate between Health and Human Services Secretary Robert F. Kennedy Jr. and the medical community. Kennedy advocates for all new vaccines to undergo placebo testing to ensure the highest standards of safety and efficacy. However, […]

Dr. Susan Monarez, a seasoned federal government scientist, recently assumed the role of Director of the Centers for Disease Control and Prevention (CDC) in late July. However, her tenure was short-lived as she decided to leave her position just weeks after taking office, leaving many questions and uncertainties in her wake. The news of Monarez’s […]

The Department of Health and Human Services, under the leadership of Robert F. Kennedy Jr., has made a significant decision to cancel contracts and withdraw funding amounting to $500 million for the development of mRNA vaccines targeting respiratory viruses such as COVID-19 and influenza. This move has sparked debates and concerns within the medical community […]

The Trump administration, led by Health Secretary Robert F. Kennedy Jr., has decided to cancel contracts and withdraw funding amounting to $500 million for vaccine development projects. This abrupt decision impacts 22 projects utilizing mRNA technology, spearheaded by major pharmaceutical companies such as Pfizer and Moderna. These projects were aimed at creating vaccines against respiratory […]

The recent decision by Health Secretary Robert F. Kennedy Jr. to terminate 22 federal contracts for mRNA-based vaccines has sparked controversy and concern among health experts. This move, which involves cutting US$500 million in funding for mRNA vaccine development, is seen as a significant setback in the fight against infectious diseases like COVID-19 and the […]

Robert F. Kennedy Jr.’s recent move to cancel $500 million in funding for vaccine development, particularly targeting mRNA technology, has sparked significant debate and concerns within the scientific community. The decision to terminate 22 projects utilizing mRNA for vaccine development, which includes potential vaccines against respiratory viruses like COVID-19 and the flu, has raised questions […]

BioNTech SE and Pfizer Inc. have made headlines with their groundbreaking LP.8.1-adapted COVID-19 vaccine, COMIRNATY® LP.8.1, which is currently awaiting approval from the European Medicines Agency. This innovative vaccine is tailored for individuals aged 6 months and above to combat COVID-19 caused by SARS-CoV-2. The recommendation for marketing authorization was based on compelling data demonstrating […]

In an anticipated move, the U.S. Food and Drug Administration’s advisory committee has advocated for COVID-19 vaccines to adjust their bullseye to the JN.1 variant. This endorsement, although not yet sanctioned by the FDA, comes at a critical juncture when the global community is grappling with the specter of variant-driven pandemics. The FDA is currently […]

A report summarizes findings from 11 research projects funded by Wellcome to address critical evidence gaps on vaccines and AMR, especially in low- and middle-income countries. In 2024, a World Health Organization study projected that vaccines could prevent over 500,000 deaths from drug-resistant infections annually, leading to significant cost savings and a reduction of 2.5 […]